Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Goodwin

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 15, 1997
Stability of sumatriptan succinate in extemporaneously prepared oral liquidsD N Fish, H D Beall, S D Goodwin, et al.
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1992
A nationwide survey of clinical laboratory methodologies for fungal infectionsS D Goodwin, J Fiedler-Kelly, T H Grasela, et al.
Clinical Pharmacy|November 1, 1987
Single-dose pharmacokinetics of cefuroxime and cefamandole in healthy subjectsP A Colaizzi, S D Goodwin, W J Poynor, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1991
Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaningD E Nix, S D Goodwin, C A Peloquin, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1991
Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection responseD E Nix, S D Goodwin, C A Peloquin, et al.
The Annals of Pharmacotherapy|February 1, 1994
Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazoleT H Grasela, S D Goodwin, M T Pasko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995
Pretreatment regimens for adverse events related to infusion of amphotericin BS D Goodwin, J D Cleary, C A Walawander, et al.
The American Journal of Medicine|November 30, 1989
Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infectionsH A Gallis, R O Brennan, S D Goodwin, et al.
Pharmacotherapy|January 1, 1990
Prospective surveillance of intravenous amphotericin B use patternsT H Grasela, S D Goodwin, M K Walawander, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1994
Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infectionS D Goodwin, H A Gallis, A T Chow, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 15, 1997
Stability of sumatriptan succinate in extemporaneously prepared oral liquidsD N Fish, H D Beall, S D Goodwin, et al.
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1992
A nationwide survey of clinical laboratory methodologies for fungal infectionsS D Goodwin, J Fiedler-Kelly, T H Grasela, et al.
Clinical Pharmacy|November 1, 1987
Single-dose pharmacokinetics of cefuroxime and cefamandole in healthy subjectsP A Colaizzi, S D Goodwin, W J Poynor, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1991
Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaningD E Nix, S D Goodwin, C A Peloquin, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1991
Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection responseD E Nix, S D Goodwin, C A Peloquin, et al.
The Annals of Pharmacotherapy|February 1, 1994
Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazoleT H Grasela, S D Goodwin, M T Pasko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995
Pretreatment regimens for adverse events related to infusion of amphotericin BS D Goodwin, J D Cleary, C A Walawander, et al.
The American Journal of Medicine|November 30, 1989
Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infectionsH A Gallis, R O Brennan, S D Goodwin, et al.
Pharmacotherapy|January 1, 1990
Prospective surveillance of intravenous amphotericin B use patternsT H Grasela, S D Goodwin, M K Walawander, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1994
Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infectionS D Goodwin, H A Gallis, A T Chow, et al.
Pageof 4